This inventor holds 1 USPTO granted patent. Top assignee: Recordati S.a. Chemical and Pharmaceutical Company. Active years: 1995.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1995
Title: Guiseppe Bottoni: Innovator in Pharmaceutical Microgranule Technology
Introduction
Guiseppe Bottoni is a notable inventor based in Bergamo, Italy. He has made significant contributions to the field of pharmaceutical technology, particularly in the preparation of microgranules for controlled-release liquid compositions. His innovative approach has the potential to enhance the efficacy of pharmaceutical products.
Latest Patents
Guiseppe Bottoni holds a patent for a process titled "Process for the preparation of microgranules suitable for suspension in." This invention focuses on a method for creating microgranules that are ideal for use in controlled-release liquid pharmaceutical compositions. By utilizing high-shear mixer-granulators within specific parameter ranges, this process yields microgranules with optimal particle size distribution, density, surface characteristics, and shape, making them particularly suitable for coating and suspension in fluids. He has 1 patent to his name.
Career Highlights
Guiseppe Bottoni is associated with Recordati S.a., a prominent chemical and pharmaceutical company. His work at Recordati has allowed him to apply his innovative ideas in a practical setting, contributing to advancements in pharmaceutical formulations.
Collaborations
Throughout his career, Guiseppe has collaborated with esteemed colleagues such as Giancarlo Santus and Roberto Golzi. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.
Conclusion
Guiseppe Bottoni's contributions to the field of pharmaceutical technology through his innovative processes for microgranule preparation highlight his role as a key inventor in this domain. His work continues to influence the development of effective pharmaceutical compositions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
